Toxicity of aromatase inhibitor
Miyashita, M.; Ishida, T.; Ohuchi, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 302-307
2015
ISSN/ISBN: 0047-1852 PMID: 25831772 Document Number: 681763
Document emailed within 1 workday
Related Documents
Kao, Y.C.; Okubo, T.; Sun, X.Z.; Chen, S. 1999: Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women Anticancer Research 19(3a): 2049-2056De Jong, P.C.; van de Ven, J.; Nortier, H.W.; Maitimu-Smeele, I.; Donker, T.H.; Thijssen, J.H.; Slee, P.H.; Blankenstein, R.A. 1997: Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole Cancer Research 57(11): 2109-2111
Takayama, K.; Bulun, S.E. 2001: Endometriosis and aromatase inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 1): 157-160
Goss, P.E.; Tye, L.M. 1997: Anastrozole: a new selective nonsteroidal aromatase inhibitor Oncology 11(11): 1697-1703; Discussion: 1707-1708
Irawan, C.; Abdulmuthalib 2005: The role of aromatase inhibitor (AI) in the treatment of breast cancer Acta Medica Indonesiana 37(1): 43-48
Ohe, E. 1994: Effects of aromatase inhibitor on sexual differentiation of SDN-POA in rats Nihon Sanka Fujinka Gakkai Zasshi 46(3): 227-234
Murray, M.; Cantrill, E.; Farrell, G.C. 1993: Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide Journal of Pharmacology and Experimental Therapeutics 265(1): 477-481
Lisianskaia, A.S.; Manikhas, G.M.; Fadeeva, E.P.; Fedosenko, K.V.; Tapil'skaia, N.I. 2010: Endometrial stromal sarcoma: complete response to therapy with aromatase-inhibitor, anastrozole Voprosy Onkologii 56(1): 91-93
Kuria, I.M.; Petekkaya, I.; Hasanov, E.; Babacan, T.; Dizdar, O.; Altundag, K. 2012: Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor Journal of BUON: Official Journal of the Balkan Union of Oncology 17(4): 798-799
Tsukagoshi, S. 2006: Introduction of new drug: letrozole, a new non-steroidal aromatase inhibitor for the treatment of postmenopausal women with breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 859-863
Van der Wall, E.; Donker, T.H.; de Frankrijker, E.; Nortier, H.W.; Thijssen, J.H.; Blankenstein, M.A. 1993: Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women Cancer Research 53(19): 4563-4566
Stein, R.C.; Dowsett, M.; Davenport, J.; Hedley, A.; Ford, H.T.; Gazet, J.C.; Coombes, R.C. 1990: Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A Cancer Research 50(5): 1381-1384
Baba, S.; Oji, Y.; Teramoto, M.; Kawabata, K.; Saito, A. 2009: A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(11): 1905-1906
Barni, S.; Lissoni, P.; Meregalli, S.; Ardizzoia, A.; Mengo, S.; Musco, F.; Merlini, D.; Tancini, G. 1998: Clinical efficacy of the aromatase inhibitor anastrozole in relation to prolactin secretion in heavily pretreated metastatic breast cancer Tumori 84(1): 45-47
Kubota, O.; Onuki, Y.; Uchiyama, T.; Oishi, K.; Takeda, M. 2012: Efficacy of high-dose toremifene as a second-line hormone therapy in patients with advanced or metastatic breast cancer resistant to aromatase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(5): 753-757
Brandt, M.E.; Puett, D.; Garola, R.; Fendl, K.; Covey, D.F.; Zimniski, S.J. 1988: Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy Progress in Clinical and Biological Research 262: 65-84
Tarkowski, R.; Skrzypczak, M.; Winiarczyk, S.; Kotarski, J.; Jakowicki, J.A.; Jakimiuk, A.J. 2000: Aromatase (P450AROM) mRNA expression in normal, hyperplastic and malignant endometrium and aromatase activity in endometrial cancer tissue culture Ginekologia Polska 71(3): 130-135
Koyama, H.; Iesato, A.; Fukushima, Y.; Okada, T.; Watanabe, T.; Harada, M.; Ito, T.; Maeno, K.; Mochizuki, Y.; Ito, K.; Amano, J. 2011: A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(7): 1123-1126
Takeda, Y.; Tanaka, N.; Konishi, J. 2012: Combination of trastuzumab, aromatase inhibitor and anti-cancer drugs obtained a good prognosis for an inoperable stage IIi B breast cancer patient with giant skin ulceration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 629-632
Nomura, Y.; Abe, O.; Tominaga, T.; Tashiro, H.; Hisamatsu, K.; Enomoto, K.; Fujiwara, K.; Imoto, S.; Ando, J.; Hayashi, K. 1994: Phase i study of CGS16949A--a new aromatase inhibitor. Cooperative Study Group for CGS16949A Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 189-197